Enhancement of tumor immunotherapy by deletion of the A2A adenosine receptor.
Waickman AT; Alme A; Senaldi L; Zarek PE; Horton M; Powell JD; Cancer Immunology, Immunotherapy: CII, 2012, vol. 61, issue 6, p 917, ISSN 14320851. ISBN 14320851.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef